Edition:
United States

Leap Therapeutics Inc (LPTX.OQ)

LPTX.OQ on NASDAQ Stock Exchange Global Market

6.77USD
15 Dec 2017
Change (% chg)

$0.10 (+1.50%)
Prev Close
$6.67
Open
$6.66
Day's High
$6.78
Day's Low
$6.65
Volume
5,647
Avg. Vol
8,984
52-wk High
$10.10
52-wk Low
$4.94

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.725
Jun '17 0.00 -0.735
Mar '17 0.00 -1.391
FY 2016 Dec '16 0.00 -0.610
Sep '16 0.00 -0.774
Jun '16
FY 2015 Dec '15 0.00 -0.369
Sep '15 0.00 -0.290
Jun '15
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 1 0.00 0.00 0.00 --
Quarter Ending Mar-18 1 0.00 0.00 0.00 --
Year Ending Dec-17 2 0.00 0.00 0.00 --
Year Ending Dec-18 2 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Dec-17 2 -0.82 -0.77 -0.87 --
Quarter Ending Mar-18 2 -0.79 -0.78 -0.79 --
Year Ending Dec-17 2 -3.63 -3.53 -3.73 --
Year Ending Dec-18 2 -2.61 -2.08 -3.13 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 198.20 35.91
P/E High - Last 5 Yrs. -- 280.37 45.35
P/E Low - Last 5 Yrs. -- 93.75 24.23
Beta -- 0.82 0.91
Price to Sales (TTM) -- 122.78 5.95
Price to Book (MRQ) 5.49 23.45 5.68
Price to Tangible Book (MRQ) 5.49 27.39 7.29
Price to Cash Flow (TTM) -- 108.78 24.49
% Owned Institutions 1.37 5.61 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 96.58 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -5.04 6.79
Sales (TTM) vs TTM 1 Yr. Ago -- 29.98 5.62
Sales - 5 Yr. Growth Rate -- 33.48 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago 6.32 -150.15 7.85
EPS (TTM) vs TTM 1 Yr. Ago -39.22 -- --
EPS - 5 Yr. Growth Rate -- 44.93 10.94
Capital Spending - 5 Yr. Growth Rate -- 41.51 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.55
Current Ratio (MRQ) 2.75 5.62 3.56
LT Debt to Equity (MRQ) 0.00 16.22 13.38
Total Debt to Equity (MRQ) 0.00 18.71 19.38
Interest Coverage (TTM) -29.87 -139.32 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.18 54.91
Gross Margin - 5 Yr. Avg. -- 55.78 52.46
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -215.66 15.63
Operating Margin (TTM) -- -642.63 6.56
Operating Margin - 5 Yr. Avg. -- -232.87 11.00
Pre-Tax Margin (TTM) -- -611.04 7.41
Pre-Tax Margin - 5 Yr. Avg. -- -233.04 11.41
Net Profit Margin (TTM) -- -608.78 3.64
Net Profit Margin - 5 Yr. Avg. -- -236.43 7.70
Effective Tax Rate (TTM) -- 15.53 24.28
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,314,532 851,801,741
Net Income/Employee (TTM) -1,374,524 -1,997,855 99,542,701
Receivable Turnover (TTM) -- 26.15 6.13
Inventory Turnover (TTM) -- 2.62 3.56
Asset Turnover (TTM) 0.00 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -284.22 -9.39 11.31
Return on Assets - 5 Yr. Avg. -- 0.28 12.28
Return on Investment (TTM) -- -11.76 14.43
Return on Investment - 5 Yr. Avg. -- 3.42 16.07
Return on Equity (TTM) -- -36.72 16.01
Return on Equity - 5 Yr. Avg. -- 5.75 17.27
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -112.71 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Leap Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 70.93%
# of Holders: 13
Total Shares Held: 6,664,124
3 Mo. Net Change: 1,099,342
# New Positions: 3
# Closed Positions: 2
# Increased Positions: 5
# Reduced Positions: 4
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.